Company intelligence / Profile preview

Radient Technologies

Edmonton, Alberta, Canadaen.wikipedia.org ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

Radient Technologies has commercialized its proprietary MAP extraction platform to produce purified cannabinoid ingredients and formulations for use in cannabis products as well as other health-related applications. The company provides white-label extracts and custom formulations with a focus on purity and quality control. No clinical trial results are reported; the business is focused on manufacturing/extraction rather than drug development.

Therapeutic areas: GastroenterologyDermatologyOther
Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Radient Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radient Technologies.

Explore the full profile